Grein Tanja A, Loewe Daniel, Dieken Hauke, Weidner Tobias, Salzig Denise, Czermak Peter
Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Giessen, Germany.
Faculty of Biology and Chemistry, Justus Liebig University, Giessen, Germany.
Front Bioeng Biotechnol. 2019 Apr 17;7:78. doi: 10.3389/fbioe.2019.00078. eCollection 2019.
Oncolytic Measles virus is a promising candidate for cancer treatment, but clinical studies have shown that extremely high doses (up to 10 TCID per dose) are required to effect a cure. Very high titers of the virus must therefore be achieved during production to ensure an adequate supply. We have previously shown that Measles virus can be produced in Vero cells growing on a Cytodex 1 microcarrier in serum-containing medium using a stirred-tank reactor (STR). However, process optimization and further process transfer or scale up requires the identification of critical process parameters, particularly because the use of STRs increases the risk of cell damage and lower product yields due to shear stress. Using a small-scale STR (0.5 L working volume) we found that Measles virus titers are sensitive to agitator-dependent shear, with shear stress ≥0.25 N m reducing the titer by more than four orders of magnitude. This effect was observed in both serum-containing and serum-free medium. At this scale, virus of titers up to 10 TCID mL could be achieved with an average shear stress of 0.1 N m. We also found that the aeration method affected the virus titer. Aeration was necessary to ensure a sufficient oxygen supply to the Vero cells, and CO was also needed to regulate the pH of the sodium bicarbonate buffer system. Continuous gassing with air and CO reduced the virus titer by four orders of magnitude compared to head-space aeration. The manufacture of oncolytic Measles virus in a STR can therefore be defined as a shear-sensitive process, but high titers can nevertheless be achieved by keeping shear stress levels below 0.25 N m and by avoiding extensive gassing of the medium.
溶瘤麻疹病毒是一种很有前景的癌症治疗候选药物,但临床研究表明,需要极高的剂量(每剂高达10个组织培养感染剂量)才能实现治愈。因此,在生产过程中必须获得非常高滴度的病毒,以确保充足的供应。我们之前已经表明,麻疹病毒可以在含有血清的培养基中,使用搅拌罐反应器(STR),在Cytodex 1微载体上生长的Vero细胞中产生。然而,工艺优化以及进一步的工艺转移或扩大规模需要确定关键工艺参数,特别是因为使用STR会增加细胞损伤的风险,并且由于剪切应力会降低产品产量。使用小规模的STR(工作体积为0.5 L),我们发现麻疹病毒滴度对搅拌器引起的剪切敏感,剪切应力≥0.25 N/m会使滴度降低四个数量级以上。在含血清和无血清培养基中均观察到这种效应。在这个规模下,平均剪切应力为0.1 N/m时,可以获得高达10个组织培养感染剂量/mL的病毒滴度。我们还发现通气方法会影响病毒滴度。通气对于确保向Vero细胞提供足够的氧气供应是必要的,并且还需要二氧化碳来调节碳酸氢钠缓冲系统的pH值。与顶空通气相比,连续通入空气和二氧化碳会使病毒滴度降低四个数量级。因此,在STR中生产溶瘤麻疹病毒可被定义为对剪切敏感的过程,但通过将剪切应力水平保持在0.25 N/m以下并避免对培养基进行大量通气,仍可获得高滴度。